Calcium Phosphate Deposition With Normal Phosphate Concentration : – Role of Pyrophosphate –
スポンサーリンク
概要
- 論文の詳細を見る
Background: Calcium phosphate deposition (CPD) is the hallmark of vascular smooth muscle cell (VSMC) calcification. CPD is a thermodynamically-favored process under physiological conditions. Hydroxyapatite, the most common calcium phosphate in calcified arteries, is passively formed during VSMC calcification, independently on any direct cellular activity. Furthermore, in recent years it has been demonstrated there is an anti-calcifying effect by extracellular pyrophosphate, an endogenous inhibitor of CPD, both in vitro and in vivo, which directly blocks hydroxyapatite formation.Methods and Results: We have used the in vitro calcification model without cellular activity, by treating confluent rat aortic VSMC with paraformaldehyde. Fixed cells were incubated with the indicated media to obtain or inhibit calcification. The calcium content was determined colorimetrically. Calcification was observed after 3 weeks (21 days) using a physiological concentration of calcium (1.8mmol/L) and phosphate (1mmol/L). Calcium deposition was directly proportional to the amount of phosphate in the media, with a calcification rate of 3.5, 7.5, and 14.3μg·cm-2·day-1, using 1, 2, and 4mmol/L of phosphate, respectively. Under physiological conditions, pyrophosphate inhibits CPD with an IC50 of ≈200nmol/L.Conclusions: CPD occurs under a physiological concentration of calcium and phosphate, but this deposition is completely inhibited in the presence of a physiological concentration of pyrophosphate (3-5μmol/L). (Circ J 2011; 75: 2705-2710)
論文 | ランダム
- イオントフォレシスによる経皮吸収に及ぼす薬物の脂溶性および極性表面積の影響
- 中温筒状横縞形SOFCの開発 (特集 SOFCの開発状況)
- Modification of Liposomes by Addition of HCO60. II. Encapsulation of Doxorubicin into Liposomes Containing HCO60
- Influence of Liposomes on Tryptic Digestion of Insulin. II
- Influence of Liposomes on Tryptic Digestion of Insulin